Research on vaccine-preventable diseases

We began our research on vaccine economics in 2001, as part of a Centers for Disease Control and Prevention (CDC)-Harvard Joint Initiative on Vaccine Economics (JIVE). Funding from this initiative supported some of our early collaboration on global poliovirus risk management, which continues to date. We recently expanded our research to focus on development of investment cases for global measles and rubella risk management. We thank many contributors for support of our vaccine-preventable disease modeling efforts. Our research on vaccine-preventable diseases led to peer-reviewed publications related to the following topics (publication dates):

You can also learn some basics about polio and measles, rubella, and Congenital Rubella Syndrome (CRS).